TCGA-E2-A159-01A-11R-A115-07
— · C
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- C
- subtype
- C
- overall_survival_months
- 25
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- ALLOGRAFT_REJECTION+0.470
- E2F_TARGETS+0.440
- G2M_CHECKPOINT+0.410
- INFLAMMATORY_RESPONSE+0.390
- IL6_JAK_STAT3_SIGNALING+0.360
- COMPLEMENT+0.350
- INTERFERON_GAMMA_RESPONSE+0.330
- MTORC1_SIGNALING+0.320
- MITOTIC_SPINDLE+0.310
- GLYCOLYSIS+0.260
Top 10 suppressed
- MYC_TARGETS_V2-0.380
- ESTROGEN_RESPONSE_EARLY-0.350
- TGF_BETA_SIGNALING-0.250
- MYOGENESIS-0.230
- OXIDATIVE_PHOSPHORYLATION-0.210
- UV_RESPONSE_DN-0.210
- ADIPOGENESIS-0.180
- ESTROGEN_RESPONSE_LATE-0.180
- ANGIOGENESIS-0.170
- FATTY_ACID_METABOLISM-0.170
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | TCGA-BH-A0BW-01A-11R-A115-07 | — | D | 0.770 |
| 2 | BSR_16_0031_E2_S98 | — | C | 0.760 |
| 3 | b4fd9abd-cb2a-4d1b-abb2-8e2796d009cc | — | — | 0.751 |
| 4 | TCGA-BH-A18V-06A-11R-A213-07 | — | D | 0.745 |
| 5 | TCGA-CR-6481-01A-11R-1873-07 | — | — | 0.743 |
| 6 | SRR1313152 | — | E | 0.742 |
| 7 | SRR8943003 | — | — | 0.737 |
| 8 | TCGA-A8-A07U-01A-11R-A034-07 | — | D | 0.735 |
| 9 | TCGA-C8-A275-01A-21R-A16F-07 | — | C | 0.733 |
| 10 | TCGA-BH-A0DL-01A-11R-A115-07 | — | E | 0.730 |